Table 2.
Relationship of Hoxd10 expression with pathological parameters of tumor
Clinical parameters | HOXD10 | |||
---|---|---|---|---|
Low | High | t/χ 2 | P | |
Age (years) | 59.77 ± 12.44 | 58.48 ± 11.85 | 1.107 | 0.269 |
Gender | 0.519 | 0.4771 | ||
Male | 135 (43.4 %) | 176 (56.6 %) | ||
Female | 59 (47.2 %) | 66 (52.8 %) | ||
Location | 4.379 | 0.112 | ||
Proximal | 31 (56.4 %) | 24 (43.6 %) | ||
Middle | 74 (45.4 %) | 89 (54.6 %) | ||
Distal | 89 (40.8 %) | 129 (59.2 %) | ||
Size | 25.716 | 0.0001 | ||
<5 cm | 88 (34.4 %) | 168 (65.6 %) | ||
≥5 cm | 106 (58.9 %) | 74 (41.1 %) | ||
Lauren classification | 63.165 | 0.0001 | ||
Intestinal | 58 (26.0 %) | 165 (74.0 %) | ||
Diffuse | 136 (63.8 %) | 77 (36.2 %) | ||
Histology classification | 7.343 | 0.062 | ||
Papillary adenocarcinoma | 3 (18.8 %) | 13 (81.2 %) | ||
Tubular adenocarcinoma | 142 (43.6 %) | 184 (56.4 %) | ||
Mucinous adenocarcinoma | 17 (58.6 %) | 12 (41.4 %) | ||
Signet-ring cell carcinoma | 32 (49.2 %) | 33 (50.8 %) | ||
Histologic differentiation | 5.25 | 0.154 | ||
Well | 3 (23.1 %) | 10 (76.9 %) | ||
Moderately | 50 (39.1 %) | 78 (60.9 %) | ||
Poorly | 140 (47.8 %) | 153 (52.2 %) | ||
Others | 1 (50.0 %) | 1 (50.0 %) | ||
Invasion depth | 33.892 | 0.0001 | ||
T1 | 9 (15.8 %) | 48 (84.2 %) | ||
T2 | 39 (35.8 %) | 70 (64.2 %) | ||
T3 | 129 (52.9 %) | 115 (47.1 %) | ||
T4 | 17 (65.4 %) | 9 (34.6 %) | ||
TNM stages | 60.859 | 0.0001 | ||
I | 17 (18.9 %) | 73 (81.1 %) | ||
II | 30 (28.8 %) | 74 (71.2 %) | ||
III | 102 (59.0 %) | 71 (41.0 %) | ||
IV | 45 (65.2 %) | 24 (34.8 %) | ||
Lymphatic metastasis | 45.165 | 0.0001 | ||
No | 40 (24.1 %) | 126 (75.9 %) | ||
Yes | 154 (57.0 %) | 116 (43.0 %) | ||
Regional lymph nodes | 51.95 | 0.0001 | ||
PN0 | 40 (24.1 %) | 126 (75.9 %) | ||
PN1 | 67 (49.3 %) | 69 (50.7 %) | ||
PN2 | 65 (65.7 %) | 34 (34.3 %) | ||
PN3 | 22 (62.9 %) | 13 (37.1 %) | ||
Distant metastasis | 14.821 | 0.0001 | ||
No | 153 (40.8 %) | 222 (59.2 %) | ||
Yes | 41 (67.2 %) | 20 (32.8 %) |